L
Lindsay Wang 2024 Study
Study / ResearchMentioned in 1 video
A study that found diabetic patients taking Ozempic were 50% less likely to develop bowel cancer compared to those on insulin, suggesting anti-cancer effects beyond weight loss.
A study that found diabetic patients taking Ozempic were 50% less likely to develop bowel cancer compared to those on insulin, suggesting anti-cancer effects beyond weight loss.